PHASE I CLINICAL TRIAL OF PEPOSERTIB PLUS RADIOTHERAPY IN ADULTS WITH NEWLY-DIAGNOSED MGMT-UNMETHYLATED GLIOBLASTOMA

被引：0

作者：

Majd, Nazanin ^{[1
]}

Liu, John ^{[2
]}

Yeboa, Nana ^{[1
]}

Wang, Shuqi ^{[1
]}

Weathers, Shiao-Pei ^{[1
]}

Yuan, Ying ^{[1
]}

Gachimova, Evguenia ^{[1
]}

Wathoo, Chetna ^{[1
]}

Kamiya-Matsuoka, Carlos ^{[1
]}

O'Brien, Barbara ^{[1
]}

Aaroe, Ashley ^{[1
]}

Patel, Chirag ^{[1
]}

Patel, Anuj ^{[1
]}

Dagher, Samir ^{[1
]}

Wintermark, Max ^{[1
]}

Ferguson, Sherise ^{[1
]}

Puduvalli, Vinay ^{[1
]}

Raleigh, David ^{[2
]}

de Groot, John ^{[2
]}

机构：

[1] MD Anderson Canc Ctr, Houston, TX USA

[2] Univ Calif San Francisco, San Francisco, CA USA

来源：

NEURO-ONCOLOGY | 2024年 / 26卷

关键词：

D O I：

10.1093/neuonc/noae165.0461

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

DNAR-10

引用

页数：1

共 50 条

[31] Phase II study to evaluate safety and efficacy of MEDI4736 (durvalumab) plus radiotherapy in patients with newly diagnosed unmethylated MGMT glioblastoma (new unmeth GBM).
Reardon, David A.
Kaley, Thomas Joseph
Dietrich, Jorg
Clarke, Jennifer Leigh
Dunn, Gavin
Lim, Michael
Cloughesy, Timothy Francis
Gan, Hui Kong
Park, Andrew J.
Schwarzenberger, Paul
Ricciardi, Toni
Macri, Mary J.
Ryan, Aileen
Venhaus, Ralph Rudolph
JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
[32] Anlotinib for patients with newly diagnosed glioblastoma with unmethylated MGMT promoter: An open-label, single-center, phase 2 clinical trial.
Yang, Kunyu
Wu, Bian
Zhang, Zhanjie
Peng, Gang
Huang, Jing
Hong, Xiaohua
Ding, Qian
Shi, Liangliang
Wang, Xuan
Zhao, Hongyang
Jiang, Xiaobing
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[33] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy for newly diagnosed glioblastoma
Ryu, Samuel
Ye, Xiaobu
Olson, Jeffrey J.
Mikkelsen, Tom
Bangiyev, Lev
Lesser, Glenn Jay
Batchelor, Tracy
Nabors, Louis B.
Desideri, Serena
Walbert, Tobias
Grossman, Stuart A.
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[34] A PHASE 0 'TRIGGER' TRIAL OF NIRAPARIB IN NEWLY-DIAGNOSED GLIOBLASTOMA PATIENTS
Sanai, Nader
Margaryan, Tigran
Molloy, Jennifer
Knight, William
Harmon, Jocelyn
Hong, Amy
Wanebo, John
Kennedy, William
Garcia, Michael
Barani, Igor
Yoo, Wonsuk
Tien, An-Chi
Tovmasyan, Artak
Mehta, Shwetal
NEURO-ONCOLOGY, 2022, 24 : 73 - 73
[35] AVAglio: Phase 3 Trial of Bevacizumab Plus Temozolomide and Radiotherapy in Newly Diagnosed Glioblastoma Multiforme
Chinot, O. L.
Rouge, T. de la Motte
Moore, N.
Zeaiter, A.
Das, A.
Phillips, H.
Modrusan, Z.
Cloughesy, T.
ADVANCES IN THERAPY, 2011, 28 (04) : 334 - 340
[36] Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter
Lim, Michael
Weller, Michael
Idbaih, Ahmed
Steinbach, Joachim
Finocchiaro, Gaetano
Raval, Raju R.
Ansstas, George
Baehring, Joachim
Taylor, Jennie W.
Honnorat, Jerome
Petrecca, Kevin
De Vos, Filip
Wick, Antje
Sumrall, Ashley
Sahebjam, Solmaz
Mellinghoff, Ingo K.
Kinoshita, Masashi
Roberts, Mustimbo
Slepetis, Ruta
Warad, Deepti
Leung, David
Lee, Michelle
Reardon, David A.
Omuro, Antonio
NEURO-ONCOLOGY, 2022, 24 (11) : 1935 - 1949
[37] AVAglio: Phase 3 trial of bevacizumab plus temozolomide and radiotherapy in newly diagnosed glioblastoma multiforme
O. L. Chinot
T. de La Motte Rouge
N. Moore
A. Zeaiter
A. Das
H. Phillips
Z. Modrusan
T. Cloughesy
Advances in Therapy, 2011, 28 : 334 - 340
[38] Paxalisib in patients with newly diagnosed glioblastoma with unmethylated MGMT promoter status: Final phase 2 study results
Wen, Patrick Y.
De Groot, John Frederick
Battiste, James
Goldlust, Samuel A.
Garner, James Stuart
Friend, John
Simpson, Jeremy Andrew
Damek, Denise
Olivero, Alan
Cloughesy, Timothy Francis
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
[39] Phase I and pharmacodynamic study of arsenic trioxide plus radiotherapy in patients with newly diagnosed glioblastoma
Ryu, Samuel
Ye, Xiaobu
Olson, Jeffrey J.
Mikkelsen, Tom
Bangiyev, Lev
Lesser, Glenn J.
Batchelor, Tracy
Nabors, Burt
Desideri, Serena
Walbert, Tobias
Grossman, Stuart A.
NEURO-ONCOLOGY ADVANCES, 2024, 6 (01)
[40] A PHASE 0/2 'TRIGGER' TRIAL OF NIRAPARIB IN PATIENTS WITH NEWLY-DIAGNOSED GLIOBLASTOMA
Sanai, Nader
Margaryan, Tigran
Molloy, Jennifer
Zhang, Hualin
Knight, William
Harmon, Jocelyn
Hong, Amy
Wanebo, John
Kennedy, William
Braun, Kelly
Garcia, Michael
Barani, Igor
Yoo, Wonsuk
Tien, An-Chi
Tovmasyan, Artak
Mehta, Shwetal
NEURO-ONCOLOGY, 2023, 25

← 1 2 3 4 5 →